Literature DB >> 10931945

TARP: a nuclear protein expressed in prostate and breast cancer cells derived from an alternate reading frame of the T cell receptor gamma chain locus.

C D Wolfgang1, M Essand, J J Vincent, B Lee, I Pastan.   

Abstract

Previously, we identified the expression of a prostate-specific form of T cell receptor gamma chain (TCRgamma) mRNA in the human prostate and demonstrated that it originates from epithelial cells and not from infiltrating T lymphocytes. Here, we show that this prostate-specific transcript is also expressed in three breast cancer cell lines and breast cancer tissues. Analysis of the cDNA sequence predicts that this transcript can encode two protein products of 7 and 13 kDa, and in vitro translation experiments showed that both proteins were made. The longer ORF encodes a 13-kDa truncated version of TCRgamma, whereas the shorter alternative reading frame encodes a 7-kDa protein with five leucine residues in heptad repeats followed by a basic region. Studies with specific antibodies against each protein product revealed that both prostate and breast cancer cells contain only the 7-kDa protein, which is located in the nucleus. We have named this protein TCRgamma alternate reading frame protein (TARP). These results demonstrate that an alternative protein product is encoded by the TCRgamma locus in cells other than T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10931945      PMCID: PMC16882          DOI: 10.1073/pnas.160270597

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  The PROSITE database, its status in 1999.

Authors:  K Hofmann; P Bucher; L Falquet; A Bairoch
Journal:  Nucleic Acids Res       Date:  1999-01-01       Impact factor: 16.971

2.  Discovery of three genes specifically expressed in human prostate by expressed sequence tag database analysis.

Authors:  G Vasmatzis; M Essand; U Brinkmann; B Lee; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

3.  Structure of the nuclear transport complex karyopherin-beta2-Ran x GppNHp.

Authors:  Y M Chook; G Blobel
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

4.  Quantitative monitoring of gene expression patterns with a complementary DNA microarray.

Authors:  M Schena; D Shalon; R W Davis; P O Brown
Journal:  Science       Date:  1995-10-20       Impact factor: 47.728

5.  Structure of phenylalanyl-tRNA synthetase from Thermus thermophilus.

Authors:  L Mosyak; L Reshetnikova; Y Goldgur; M Delarue; M G Safro
Journal:  Nat Struct Biol       Date:  1995-07

6.  High expression of a specific T-cell receptor gamma transcript in epithelial cells of the prostate.

Authors:  M Essand; G Vasmatzis; U Brinkmann; P Duray; B Lee; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

7.  Gene expression profiles in normal and cancer cells.

Authors:  L Zhang; W Zhou; V E Velculescu; S E Kern; R H Hruban; S R Hamilton; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1997-05-23       Impact factor: 47.728

8.  PAGE-1, an X chromosome-linked GAGE-like gene that is expressed in normal and neoplastic prostate, testis, and uterus.

Authors:  U Brinkmann; G Vasmatzis; B Lee; N Yerushalmi; M Essand; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

9.  The crystal structure of pyrimidine nucleoside phosphorylase in a closed conformation.

Authors:  M J Pugmire; S E Ealick
Journal:  Structure       Date:  1998-11-15       Impact factor: 5.006

10.  The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines.

Authors:  S Majumdar; E P Diamandis
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

View more
  29 in total

1.  Cloning of B cell lymphoma-associated antigens using modified phage-displayed expression cDNA library and immunized patient sera.

Authors:  Soung-Chul Cha; Larry W Kwak; Pier Adelchi Ruffini; Hong Qin; Sattva Neelapu; Arya Biragyn
Journal:  J Immunol Methods       Date:  2006-03-31       Impact factor: 2.303

Review 2.  Strategies to use immune modulators in therapeutic vaccines against cancer.

Authors:  Jay A Berzofsky; Masaki Terabe; Lauren V Wood
Journal:  Semin Oncol       Date:  2012-06       Impact factor: 4.929

3.  T cells engineered with a T cell receptor against the prostate antigen TARP specifically kill HLA-A2+ prostate and breast cancer cells.

Authors:  Victoria Hillerdal; Berith Nilsson; Björn Carlsson; Fredrik Eriksson; Magnus Essand
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-10       Impact factor: 11.205

4.  POTE, a highly homologous gene family located on numerous chromosomes and expressed in prostate, ovary, testis, placenta, and prostate cancer.

Authors:  Tapan K Bera; Drazen B Zimonjic; Nicholas C Popescu; Bangalore K Sathyanarayana; Vasantha Kumar; Byungkook Lee; Ira Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-10       Impact factor: 11.205

5.  PATE, a gene expressed in prostate cancer, normal prostate, and testis, identified by a functional genomic approach.

Authors:  Tapan K Bera; Rangan Maitra; Carlo Iavarone; Giuliana Salvatore; Vasantha Kumar; James J Vincent; B K Sathyanarayana; Paul Duray; B K Lee; Ira Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

6.  Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression.

Authors:  Sandra M Lopez; Alexander I Agoulnik; Manqi Zhang; Leif E Peterson; Egla Suarez; Gregory A Gandarillas; Anna Frolov; Rile Li; Kimal Rajapakshe; Christian Coarfa; Michael M Ittmann; Nancy L Weigel; Irina U Agoulnik
Journal:  Clin Cancer Res       Date:  2016-03-11       Impact factor: 12.531

Review 7.  Cancer vaccines: translation from mice to human clinical trials.

Authors:  Hoyoung Maeng; Masaki Terabe; Jay A Berzofsky
Journal:  Curr Opin Immunol       Date:  2018-03-16       Impact factor: 7.486

8.  A novel role of myosin VI in human prostate cancer.

Authors:  Thomas A Dunn; Shenglin Chen; Dennis A Faith; Jessica L Hicks; Elizabeth A Platz; Yidong Chen; Charles M Ewing; Jurga Sauvageot; William B Isaacs; Angelo M De Marzo; Jun Luo
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

9.  TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancer.

Authors:  Lauren V Wood; Antonio Fojo; Brenda D Roberson; Meghan S B Hughes; William Dahut; James L Gulley; Ravi A Madan; Philip M Arlen; Marianna Sabatino; David F Stroncek; Luciano Castiello; Jane B Trepel; Min-Jung Lee; Howard L Parnes; Seth M Steinberg; Masaki Terabe; Julia Wilkerson; Ira Pastan; Jay A Berzofsky
Journal:  Oncoimmunology       Date:  2016-07-01       Impact factor: 8.110

10.  Role of the TMPRSS2-ERG gene fusion in prostate cancer.

Authors:  Scott A Tomlins; Bharathi Laxman; Sooryanarayana Varambally; Xuhong Cao; Jindan Yu; Beth E Helgeson; Qi Cao; John R Prensner; Mark A Rubin; Rajal B Shah; Rohit Mehra; Arul M Chinnaiyan
Journal:  Neoplasia       Date:  2008-02       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.